n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Hypotension in 1 studies
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaiser, B | 1 |
| Hauptmann, J | 1 |
| Weiss, A | 1 |
| Markwardt, F | 1 |
1 other study available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Hypotension
| Article | Year |
|---|---|
Pharmacological characterization of a new highly effective synthetic thrombin inhibitor.
Topics: Animals; Blood Coagulation Disorders; Dipeptides; Hypotension; Kinetics; Lethal Dose 50; Liver; Mice | 1985 |